Staar Surgical Co STAA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
STAAR Surgical Names Andrew Pilon as Vice President of Business Development
-
STAAR Surgical Board Approves $50 Million Share Repurchase Authorization
-
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of STAAR Surgical Company (NASDAQ: STAA).
-
STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction
-
STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer
-
STAAR Surgical Names Medtech Innovator and Platform Builder Ben Park as Chief Technology Officer
-
STAAR Surgical Reports Second Quarter 2026 Results
-
STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer
Trading Information
- Previous Close Price
- $22.01
- Day Range
- $21.25–22.09
- 52-Week Range
- $15.60–35.66
- Bid/Ask
- $21.27 / $21.40
- Shares Outstanding
- 50.14M
- Market Cap
- $1.07B
- Volume/Avg
- 34,427 / 997,353
Key Statistics
- Price/Earnings (Normalized)
- 23.44
- Price/Sales
- 3.27
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 0.61%
Company Profile
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Core
- Total Number of Employees
- 957
- Website
- https://www.staar.com
Valuation
|
Metric
|
STAA
|
|---|---|
Price/Earnings (Normalized) | 23.44 |
Price/Book Value | 3.00 |
Price/Sales | 3.27 |
Price/Cash Flow | 15.44 |
Price/Earnings
STAA
Financial Strength
|
Metric
|
STAA
|
|---|---|
Quick Ratio | 3.86 |
Current Ratio | 4.66 |
Interest Coverage | — |
Quick Ratio
STAA
Profitability
|
Metric
|
STAA
|
|---|---|
Return on Assets (Normalized) | 12.92% |
Return on Equity (Normalized) | 16.75% |
Return on Invested Capital (Normalized) | 14.35% |
Return on Assets
STAA
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|mbSn?>j | LOCK|tm | $151B | |||
| Becton Dickinson & Co
BDX
| LOCK|Zr | LOCK|%CGhl | $51B | |||
| ResMed Inc
RMD
| LOCK|%yq%B<%T | LOCK|pRzgG | $33B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|clD?s@P | LOCK|>g<nk | $31B | |||
| Alcon Inc
ALC
| LOCK|V!ScM% | LOCK|C>Ff& | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|&J@dXNvh | LOCK|pf | $26B | |||
| Solventum Corp
SOLV
| LOCK|&<G!@C | LOCK|v%s | $15B | |||
| Baxter International Inc
BAX
| LOCK|&V | LOCK|j^t%% | $13B | |||
| Repligen Corp
RGEN
| LOCK|@?lXVj< | LOCK|#$@p | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|ZtK%kDt | LOCK|bTy?& | $11B |
United States